This chapter explores the wide-ranging health benefits of a weight-loss drug beyond its primary function, while grappling with the ethical and financial implications of its widespread use. Discussions include Medicare's consideration of covering the drug for its heart benefits, concerns over taxpayer funding, and the challenges of combatting obesity comprehensively.